IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 945-951

  Leite De Moraes, M C ^a   Hameg, A ^a   Pacilio, M ^a   Koezuka, Y ^a   Taniguchi, M ^a   Van Kaer, L ^a   Schneider, E ^a   Dy, M ^a   Herbelin, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOREGULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; TH1 CELL; TH2 CELL;

EID: 0035863814     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.945     Document Type: Article

References (47)

1. NKT cells: A potent cytokine-producing cell population
2. Mouse CD1-specific NK1 T cells: Development, specificity, and function
3. CD1d-restricted and TCR-mediated activation of Va14 NKT cells by glycosylceramides
4. Murine CD1d-restricted T cell recognition of cellular lipids
5. CD4POs, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
6. + T cells are a potential source of IL-4 during primary immune response
7. + T cells in a TH2 response and in immanoglobulin E production
8. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
9. Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis
10. + T cells from interleukin-7 deficient mice have a normal distribution and selection but exhibit impaired cytokine production
11. + T cell defective IL-4 production in the non-obese diabetic mouse
12. + thymocytes
13. + T cells
14. The IL-4-producing NKT cells are biased towards IFN-γ production by IL-12: Influence of the microenvironment on the functional capacities of NKT cells
15. A distinct IL-18-induced pathway to fully activate NKT lymphocytes independently from TCR engagement
16. Cloning of a new cytokine that induces IFN-γ production by T cells
17. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production
18. Activation of interferon-γ inducing factor mediated by interleukin-1 β converting enzyme
19. Interleukin-18: Biological properties and clinical implications
20. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects
21. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
22. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
23. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
24. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
25. IFN-γ-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma
26. Mice lacking MHC class II molecules
27. Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors
28. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
29. Structure-activity relationship of α-galactosylceramides against B16-bearing mice
30. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains
31. + thymocytes selected by MHC class I molecules
32. + NKT lymphocytes
33. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducting interleukin (IL)-12 production by dendritic cells and 1L-12 receptor expression on NKT cells
34. IL-12 up-regulated IL-18R expression on T cells. Th1 cells and B cells: Synergism with IL18 for IFN-γ production
35. Determination of lymphocyte division by flow cytometry
36. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis
37. NF-κB in Th2 cells: Delayed and long-lasting induction through the TCR complex
38. + T lymphocytes
39. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of murine IL-4 gene
40. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
41. IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response
42. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils
43. α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells
44. Cytokines induce the development of functionally heterogeneous T helper cell subsets
45. + -like thymocytes in the NOD mouse
46. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin(IL)-4 and/or IL-10
47. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes